Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAFE
3526
Safehold
SAFE
$1.18B
| $295K | ﹤0.01% |
6,187
-16,043
| -72% | -$773K |
|
|
ZIMV
3527
DELISTED
ZimVie
ZIMV
| $294K | ﹤0.01% |
31,465
+4,646
| +17% | +$40.6K |
|
3528
Fulgent Genetics
FLGT
$500M
| $294K | ﹤0.01% |
9,862
+4,552
| +86% | +$163K |
|
3529
Unisys
UIS
$218M
| $292K | ﹤0.01% |
57,203
+39,506
| +223% | +$248K |
|
3530
Dolby
DLB
$5.59B
| $292K | ﹤0.01% |
4,140
-11,797
| -74% | -$813K |
|
|
BHR
3531
Braemar Hotels & Resorts
BHR
$148M
| $292K | ﹤0.01% |
70,966
+15,479
| +28% | +$63.5K |
|
3532
Rayonier Advanced Materials
RYAM
$608M
| $291K | ﹤0.01% |
30,345
+13,860
| +84% | +$88.2K |
|
3533
Open Text
OTEX
$6.34B
| $291K | ﹤0.01% |
9,828
-33,907
| -78% | -$961K |
|
|
TCS
3534
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $290K | ﹤0.01% |
4,489
+328
| +8% | +$23.7K |
|
3535
Daktronics
DAKT
$1,000M
| $290K | ﹤0.01% |
102,814
-20,856
| -17% | -$64.1K |
|
3536
PUT
Blackstone
BX
$108B
| $289K | ﹤0.01% |
+3,900
| New | +$337K |
|
3537
Orion
OEC
$385M
| $289K | ﹤0.01% |
16,245
+13,680
| +533% | +$230K |
|
3538
Procept Biorobotics
PRCT
$1.05B
| $289K | ﹤0.01% |
6,960
+5,875
| +541% | +$252K |
|
3539
Perimeter Solutions
PRM
$4.98B
| $288K | ﹤0.01% |
31,522
+26,356
| +510% | +$232K |
|
3540
Organogenesis Holdings
ORGO
$301M
| $287K | ﹤0.01% |
106,791
+67,203
| +170% | +$196K |
|
|
PEGR
3541
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $287K | ﹤0.01% |
28,466
| – | – |
|
|
SAL
3542
DELISTED
Salisbury Bancorp, Inc.
SAL
| $287K | ﹤0.01% |
9,129
-2,448
| -21% | -$68.9K |
|
3543
CALL
Fastly Inc
FSLY
$3.6B
| $287K | ﹤0.01% |
+35,000
| New | +$307K |
|
3544
AN2 Therapeutics
ANTX
$201M
| $286K | ﹤0.01% |
30,058
+2,780
| +10% | +$37.2K |
|
3545
Dorian LPG
LPG
$1.97B
| $286K | ﹤0.01% |
15,105
+1,835
| +14% | +$32.9K |
|
3546
Construction Partners
ROAD
$6.11B
| $286K | ﹤0.01% |
10,711
+8,897
| +490% | +$255K |
|
3547
CALL
Weyerhaeuser
WY
$18.2B
| $285K | ﹤0.01% |
+9,200
| New | +$285K |
|
3548
CEVA Inc
CEVA
$927M
| $285K | ﹤0.01% |
11,124
+5,001
| +82% | +$135K |
|
|
STKL
3549
DELISTED
SunOpta
STKL
| $284K | ﹤0.01% |
33,681
+22,085
| +190% | +$209K |
|
|
HAYN
3550
DELISTED
Haynes International, Inc.
HAYN
| $284K | ﹤0.01% |
6,221
+2,671
| +75% | +$125K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.